Past events by AAPS-BADG  

January 22nd, 2025

Workshop: Small Molecule Formulation Development — Strategies for challenging APIs (jointly with PBSS and Syner-G)

 Dan Yin, PhD, Senior Director, Formulation and Process Development department, Gilead Sciences
Formulation – A Bridge from the Chemist’s Flask to the Patient’s Bedside Registration

Jing Ling, PhD, Associate Principal Scientist, Discovery Pharmaceutical Sciences, Merck
Preclinical Formulation Development of Small Molecules

Dennis Leung, PhD, Director and Senior Principal Scientific Manager of Discovery Pharmaceutics, Genentech
Formulating Safety: Delivery Strategies for Effective Toxicology Studies

Mayuri Mutha, MS, Consultant I, Technical, Syner-G BioPharma Group
Accelerating Early Oral Formulation Development for First-in-Human Trials: Fit-for-Purpose Strategies and Innovative Approaches

Edward Yost, Scientist 4, Synthetic Molecule Pharmaceutics, Genentech
Comparing Oral Drug Delivery Systems: Tablets vs. Capsules in Early Clinical Development

Mei Lai, PhD, Principal, Web Pharma
Practical Parenteral Drug Formulation Development for Phase 1

Jennifer Yang, PhD, Independent DMPK/Clinical Pharmacology Consultant
Impact of Formulation on PK Performance

September 12th

Biomimetic Polymer Technologies for Improving Biologic Formulation and Delivery​​​​​​​

Speaker: Eric Appel, Ph.D. 
Department of Materials Science and Engineering, Schools of Engineering, Stanford University

and poster presentations from the University of the Pacific:
Rabeya Bosri
Structural characterization of dual threat Pt-HDACi anticancer agents by collision induced dissociation tandem mass spectrometry
Zara Bukhari
Precision tools for unravelling the cellular complexity: Targeting Ube2D E2 conjugating enzyme with engineered chimeric protein inhibitor
Kim Harvey
Effective Acidities of Isomeric Asp-PolyPro Peptides in the Gas-Phase and in Solution

May16th, 2024

(jointly with the AAPS Inhalation and Nasal Community)

Current Opportunities in Nasal Drug Delivery
Speaker: Julie D. Suman, R.Ph., Ph.D. (Vice President Scientific Affairs, Aptar Pharma)
and
Dry Powder Inhaler Manufacturing: Case Studies on How Powder Properties Influence Processing and Performance
Speaker: Irene Rossi, Ph.D. (Consultant Inhalation Technology , Harro Höfliger (DE))

November 8th, 2023

The Explanation For Why and Regulatory Implications When Bioavailability Calculations Exceed Unity

Speaker: Leslie Z. Benet, PhD
​​​​​​​Department of Bioengineering and Therapeutic Sciences
Schools of Pharmacy and Medicine, University of California San Francisco

May 11th, 2023

Predictive high-throughput screening of oligonucleotide lipid nanoparticle for gene silencing

Speaker: Chun-Wan Yen, PhD (Sr. Principal Scientist, Genentech)

October 3th, 2022

Beta-glucuronidase: roles in enterohepatic recirculation and prostate

Speaker: Abby C. Collier, PhD (Professor, The University of British Columbia)

June 6, 2022

Basic tenets of ADC PK/PD and examples of how M&S can be used to support MIDD of ADCs
Speaker:  Dhaval Shah, PhD (University of Buffalo )
and 
Formulation Strategies for Antibody Drug Conjugates (ADCs)
Speaker: Rajiv Nayar, PhD  (HTD Biosystems)

February 23, 2022

Local Treatment of Non-Small-Cell Lung Cancer by Dry Powder Inhaler: A Spray Dried Bevacizumab Formulation
Speaker:  Kimberly B. Shepard, PhD (Lonza Bend, OR, USA )

December 6, 2021

Gamma-Hydroxybutyric Acid Toxicokinetics and Toxicodynamics: Role of Monocarboxylate Transporters
Speaker:  Marilyn E. Morris, PhD  (University at Buffalo )

July 29-30, 2021

Development of Inhalation Therapeutics (a joint symposium with PBSS)
Speakers: 
Guenther Hochhaus (University of Florida)
Qi (Tony) Zhou (Purdue University)
Winlei Jiang (CDER, FDA)
Reinhard Vehring (University of Alberta)
Yoen-Ju Son (Genentech)
Ram Mahato (University of Nebraska)
Hugh Smyth (University of Texas, Austin)
Jennifer Wylie (Merck)

March 29, 2021

Developing Therapeutic Materials to Redirect Cellular Chatter
Speaker:  Juliane Nguyen, PharmD, PhD (University of North Carolina at Chapel Hill)

December 8, 2020

Challenges and Opportunities in Pharmaceutical Industry
Speaker:  Annette Bak, PhD (AstraZeneca)


February 11, 2020

Applying machine learning and artificial intelligence to the development of a pharmaceutical tablet (jointly with Bio2Device)
Speaker: Edward Yost (Genentech)

November 21st, 2019

Choosing Wisely: The Last Crusade for Oral Peptides
Speaker: Dennis H. Leung, PhD (Genentech)

The Best Model of a Cat Is a Cat
Synthetic biology and data sciences to navigate biological complexity
Speaker: Sridhar Govindarajan, PhD (Co-Founder/CIO – ATUM)

September 27th, 2018 

Workshop: Small Molecule Formulation Development — Strategies for challenging APIs (jointly with PBSS)

June 7th, 2018

Particle Engineering and Characterization of Pharmaceutical Solids for Small and Large Molecules
Speaker: Qi (Tony) Zhou, PhD – Purdue University

Cyclodextrins as Solubilization Tools for BCS Class II/IV Drugs & Biomolecules Stabilizers
Speaker: Carmen Popescu, PhD – Roquette America Inc.

March 8th, 2018 

Pharmaceutical Innovation in Academia
Speaker: Howard Maibach, MD, UCSF

Real-time GMP Manufacture of Injectable Formulations for Clinical Development: Where the Requirements of Science and Quality Meet
Speaker: Kevin M Kane, PhD, Quotient Sciences

October, 25th 2017 

Systemic Concentrations Can Limit the Oral Absorption of Poorly Soluble Drugs: An Investigation of Non-Sink Permeation Using Physiologically Based Pharmacokinetic Modeling
Speaker: Tom Chiang, Ph.D.,  Genentech, Inc

Defining in-vitro-in-vivo Relationships for Orally Inhaled and Nasal Drug Products
Speaker: Jag Shur, Ph.D., Nanopharm Ltd. UK
Photo of two men shaking handsPhoto of two men shaking hands

June 8, 2017

Back to the Future: Aerosol Treatment and Prevention of Tuberculosis 
Speaker: Anthony J Hickey, Ph.D.,RTI International, RTP, NC                   

3-D Printed Pharmaceutical Dosage
Speaker: Xiaoling Li, Ph.D., University of the Pacific, Stockton, CA  

March 30, 2017

Characterization of Polymorphs, Amorphous Solid Dispersions, and Proteins in Lyophilized Formulations Using Solid-State NMR Spectroscopy​​​​​​​
Speaker: Dr. Eric Munson, Professor in Pharmaceutical Sciences,
Univ. of Kentucky.

March 9, 2017

Systems based Pharmaceutics: Leveraging Mechanistic Process Modeling Tools to Meet Regulatory Requirements
Speaker: Dan Briado Senior Technical Consultant, Process Systems Enterprise Ltd. 

Developing Palatable Drug Products: It’s More than Yuck and Yum
Speaker: David A. Tisi, Technical Director, Senopsys LLC

June 19, 2014

Understanding Complex Systems: The Map is Not the Territory
Speaker: Dr. Rasmus Gronfeldt Winther, Associate Professor of Philosophy, UC Santa Cruz.

PKPD Considerations for the Preclinical Development of Antibody-Drug Conjugates
Speaker: Dr. Shraddha Sadekar, Senior Scientist, DMPK and Disposition, Merck Research Laboratories, Palo Alto.

Older Events

3/27/2014

Pediatric Drugs – A Review of Commercially Available Oral Drug Products
Speaker: Dr. Robert Strickley, Principal Scientist, Gilead Sciences Inc.

Strengthening Weaker Joints: Discovery of a New Drug Candidate for Trasnthyrethin-Folding Diseases
Speaker: Dr. Mamoun Alhamadsheh, Dept. of Pharmaceutics & Medicinal Chemistry, University of the Pacific.


9/12/2013

Overcoming the Cold-Chain: Designing a Novel Freeze-Stable Vaccine
Speaker: Aryo Sorayya, President, Engimata Inc.

Models and Their Utility in the Drug Development Process
Speaker: Dr.  Toufigh Gordi, President of PK/PD and Clinical Pharmacology Services, Rose & Co LLC.

5/09/2013

Protein Particulates and Immunogenicity
Speaker: Dr. Valerie Quarmby,  Principal Scientist and Director, Genentech:

Immunogenicity in Biotherapeutic Development
Speaker: Dr. Hanns-Christian Mahler, Head Pharmaceutical Development & Supplies, F. Hoffmann-LaRoche Ltd., Pharmaceutical Division, Pharma Technical Development Biologics Europe: “To See or Not to See? – Particulates in Protein Pharmaceuticals”

3/07/2013

Formulation Development of  Monoclonal Antibodies
Speaker: Dr. Steve Shire,  Staff Scientist, Late Stage Pharmaceutical Development, Genentech: “Challenges in the Development of Formulations for the Delivery of Monoclonal Antibody Therapeutics.”

Speaker: Dr. Mitra Mosharraf, Chief Scientific Officer, HTD Biosystems: “Strategies to Improve Dissolution Rate of Lyophilized High Dose Protein Formulations in Dual Chamber Syringes.”

11/13/2012

“Oxidative Degradation of Pharmaceuticals”
Speaker: Dr. Christian Schoneich,  Takeru Higuchi Distinguished Professor and Chair, Dept. Pharmaceutical Chemistry, Univ. of Kansas: “Oxidative degradation of pharmaceuticals: mechanisms and commonalities between small molecules, peptides, and proteins.”
Speaker: Dr. Andrea Ji, Senior Scientist, Late Stage Pharmaceutical Development, Genentech: “Oxidative degradation of pharmaceutical excipients.”

07/19/2012

“Solving Drug Metabolism Challenges”
Speaker: Cyrus Khojasteh, PhD, Group Leader, DMPK Genentech
Speaker: Jason Halladay, PhD, Scientist, DMPK Genentech

04/12/2012

“New Approaches of Drug Delivery: from Particulates to Cells”
Speaker: Xin Guo, PhD: “Design of biocompatible pH-sensitive liposomes for drug and gene delivery”
Speaker: Kevin Healy, PhD: “Bioinspired Approaches for Drug Delivery and Tissue Engineering”

12/01/2011

“Excipients and Drug Delivery”
Speaker: Narsi Rangachari, Ph.D. “Drug Delivery – A Prespective”
Speaker: Robert Strickley, Ph.D.  “Formulations in Drug Discovery…”

10/28/2011

“The Development of Biosimilar Drugs, Opportunities and Challenges”
SPEAKER:  YING-FEI WEI, PH.D.

06/29/2011

Why aren’t there more parenterally administered nanocarrier drug products? 
Speaker: Francis C. Szoka, PhD

Recent Innovations of liposomal products in drug development
Speaker: Rajiv Nayar, PhD

 02/25/2011

Pharmaceutical Excipients – Adding Functionality to Product Development
(joint event with CACO)

 09/09/2010

Antibody Drug Conjugate/The Prospect of Therapeutic Antibodies
Speakers:      Shrikant Deshpande, PhD/Xiaodong Yang, MD PhD

 05/06/2010

Risk Management and Protein Formulation in Drug Development
Speakers:       Vijay Chiruvolu, PhD, Tim Kamerzell, PhD

 1/20/2010

Poorly Soluble Drugs-Pharmaceutical Development Strategies and
Approaches for Pre Clinical Applications (joint event with CACO)
Speakers:     Ram Nyshadham, Karthik Nagapudi, Sreekanth Nadkarni, Sesha Neravennan